Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

Daridorexant 25 mg - Phase 2 | IDRS.SW Pipeline | CatalystAlert

Back to IDRS.SW

Daridorexant 25 mg

Phase 2

Idorsia Ltd (IDRS.SW)

16%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Mar 2026~

IDRS.SWPhase 2Phase 2

Daridorexant 25 mg Phase 2 Results Expected

Daridorexant 25 mg • Insomnia

Drug Information

Target Indication

Insomnia

Clinical Trial

Last updated: 12/4/2025

Developer

IDRS.SW

Idorsia Ltd

Biotechnology•North America•SIX